Novedo (NOVEDO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Jul, 2026Executive summary
Net sales for Q3 2025 decreased by 2.2% year-over-year to SEK 701.7 million, with organic growth at -7.4%.
EBITA rose slightly to SEK 70.3 million, with a margin of 10.0%, while EBIT remained flat at SEK 55.0 million.
For the nine months, net sales declined 3.0% to SEK 2,108.5 million, and EBITA dropped 26.1% to SEK 162.1 million.
Market conditions remained cautious due to geopolitical uncertainty and weak economic growth, but the Industrial segment and acquisitions supported margin improvement.
The group completed its first acquisition in Finland (UKR Oy) and closed the acquisition of Falks Markentreprenad AB after the period.
Financial highlights
Q3 net sales: SEK 701.7 million (down 2.2% YoY); nine months: SEK 2,108.5 million (down 3.0% YoY).
Q3 EBITA: SEK 70.3 million (up from 69.4); margin 10.0% (up from 9.7%).
Q3 EBIT: SEK 55.0 million (flat YoY); nine months EBIT: SEK 117.0 million (down 33.6% YoY).
Cash flow from operating activities for Q3: SEK 44.7 million (down from 55.9); nine months: SEK 87.3 million (down from 92.4).
Profit/loss for Q3: SEK -41.2 million; nine months: SEK -185.2 million.
Outlook and guidance
Management expects the market climate to remain cautious, with demand varying by segment and geography.
Long-term growth is anticipated from interest rate cuts, infrastructure investments, and regional industrial production.
Companies are adapting costs and capacity to current conditions while preparing for future growth.
Latest events from Novedo
- Strong sales and EBITA growth, led by Infrastructure, with major financing actions ahead.NOVEDO
Q2 202423 Jul 2026 - Strong sales and margin growth, robust cash flow, and major refinancing amid market uncertainty.NOVEDO
Q3 202423 Jul 2026 - Strong sales growth and stable margins driven by infrastructure, with robust refinancing and acquisitions.NOVEDO
Q4 202423 Jul 2026 - Q1 2025 saw lower sales and margins but stronger cash flow and improved net debt/EBITDA.NOVEDO
Q1 202523 Jul 2026 - H1 2025 saw lower sales and earnings amid market caution, but strategic moves support future growth.NOVEDO
Q2 202523 Jul 2026 - Net sales fell 2.8% and EBITA margin dropped to 7.6%, but order intake and cash flow improved.NOVEDO
Q4 202523 Jul 2026 - Winter disruptions and one-offs drove weak Q1 earnings despite modest sales growth.NOVEDO
Q1 202623 Jul 2026 - Q2 2026 saw 18% sales growth and a strong order book, with profitability rebounding as demand improves.NOVEDO
Q2 202623 Jul 2026